Qualigen Therapeutics Inc (QLGN)
0.301
+0.01
(+3.69%)
USD |
NASDAQ |
May 03, 16:00
0.3067
+0.01
(+1.89%)
After-Hours: 20:00
Qualigen Therapeutics 1 Year Total Returns (Daily): -67.98% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -67.98% |
May 02, 2024 | -70.97% |
May 01, 2024 | -67.84% |
April 30, 2024 | -68.06% |
April 29, 2024 | -68.57% |
April 26, 2024 | -67.63% |
April 25, 2024 | -66.63% |
April 24, 2024 | -67.62% |
April 23, 2024 | -67.53% |
April 22, 2024 | -69.56% |
April 19, 2024 | -67.26% |
April 18, 2024 | -67.19% |
April 17, 2024 | -70.41% |
April 16, 2024 | -68.44% |
April 15, 2024 | -66.33% |
April 12, 2024 | -63.68% |
April 11, 2024 | -58.92% |
April 10, 2024 | -59.36% |
April 09, 2024 | -54.27% |
April 08, 2024 | -56.26% |
April 05, 2024 | -56.23% |
April 04, 2024 | -58.56% |
April 03, 2024 | -54.20% |
April 02, 2024 | -56.76% |
April 01, 2024 | -57.30% |
Date | Value |
---|---|
March 28, 2024 | -55.06% |
March 27, 2024 | -55.36% |
March 26, 2024 | -58.34% |
March 25, 2024 | -60.00% |
March 22, 2024 | -61.29% |
March 21, 2024 | -67.74% |
March 20, 2024 | -63.18% |
March 19, 2024 | -64.23% |
March 18, 2024 | -63.49% |
March 15, 2024 | -63.35% |
March 14, 2024 | -60.78% |
March 13, 2024 | -61.65% |
March 12, 2024 | -62.51% |
March 11, 2024 | -62.49% |
March 08, 2024 | -65.38% |
March 07, 2024 | -68.25% |
March 06, 2024 | -64.04% |
March 05, 2024 | -64.22% |
March 04, 2024 | -63.53% |
March 01, 2024 | -60.28% |
February 29, 2024 | -59.84% |
February 28, 2024 | -58.98% |
February 27, 2024 | -56.62% |
February 26, 2024 | -50.13% |
February 23, 2024 | -55.90% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.97%
Minimum
Nov 23 2022
9.52%
Maximum
Feb 28 2020
-67.50%
Average
-71.75%
Median
Jan 12 2022
1 Year Total Returns (Daily) Benchmarks
Marizyme Inc | -42.26% |
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |